JP2023505684A5 - - Google Patents

Info

Publication number
JP2023505684A5
JP2023505684A5 JP2022534848A JP2022534848A JP2023505684A5 JP 2023505684 A5 JP2023505684 A5 JP 2023505684A5 JP 2022534848 A JP2022534848 A JP 2022534848A JP 2022534848 A JP2022534848 A JP 2022534848A JP 2023505684 A5 JP2023505684 A5 JP 2023505684A5
Authority
JP
Japan
Application number
JP2022534848A
Other languages
Japanese (ja)
Other versions
JP7649560B2 (ja
JPWO2021116005A5 (https=
JP2023505684A (ja
Filing date
Publication date
Priority claimed from PCT/EP2019/084287 external-priority patent/WO2021115560A1/en
Application filed filed Critical
Publication of JP2023505684A publication Critical patent/JP2023505684A/ja
Publication of JPWO2021116005A5 publication Critical patent/JPWO2021116005A5/ja
Publication of JP2023505684A5 publication Critical patent/JP2023505684A5/ja
Application granted granted Critical
Publication of JP7649560B2 publication Critical patent/JP7649560B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022534848A 2019-12-09 2020-12-07 新規fyn及びvegfr2キナーゼ阻害剤 Active JP7649560B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EPPCT/EP2019/084287 2019-12-09
PCT/EP2019/084287 WO2021115560A1 (en) 2019-12-09 2019-12-09 New fyn and vegfr2 kinase inhibitors
PCT/EP2020/084847 WO2021116005A1 (en) 2019-12-09 2020-12-07 New fyn and vegfr2 kinase inhibitors

Publications (4)

Publication Number Publication Date
JP2023505684A JP2023505684A (ja) 2023-02-10
JPWO2021116005A5 JPWO2021116005A5 (https=) 2023-12-07
JP2023505684A5 true JP2023505684A5 (https=) 2023-12-07
JP7649560B2 JP7649560B2 (ja) 2025-03-21

Family

ID=69105765

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022534848A Active JP7649560B2 (ja) 2019-12-09 2020-12-07 新規fyn及びvegfr2キナーゼ阻害剤

Country Status (6)

Country Link
US (1) US12509446B2 (https=)
EP (1) EP4073057B1 (https=)
JP (1) JP7649560B2 (https=)
CN (1) CN115279747B (https=)
ES (1) ES2972638T3 (https=)
WO (2) WO2021115560A1 (https=)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1127051A2 (en) 1998-11-06 2001-08-29 Basf Aktiengesellschaft Tricyclic pyrazole derivatives
JP4808409B2 (ja) * 2005-01-14 2011-11-02 株式会社日立製作所 センサネットワークシステム、センサデータの検索方法及びプログラム
DE602006010665D1 (en) 2005-02-07 2010-01-07 Hoffmann La Roche Heterocyclsche substituierte phenylmethanone als inhibitoren des glycintransporters 1
JP2009541480A (ja) 2006-06-30 2009-11-26 アストラゼネカ アクチボラグ 癌の治療において有用なピリミジン誘導体
JP5301469B2 (ja) 2007-02-26 2013-09-25 メルク カナダ インコーポレイテッド Ep4受容体アンタゴニストとしてのインドール及びインドリンシクロプロピルアミド誘導体
AU2008266290A1 (en) 2007-06-15 2008-12-24 Irm Llc Protein kinase inhibitors and methods for using thereof
JP2011506454A (ja) 2007-12-13 2011-03-03 グラクソスミスクライン エルエルシー チアゾールおよびオキサゾールキナーゼ阻害薬
ES2623652T3 (es) * 2011-12-28 2017-07-11 Allergan, Inc. Derivados de 3-fenil-5-ureidoisotiazol-4-carboximida y 3-amino-5-fenilisotiazol como inhibidores de cinasa
EP3070084A1 (en) * 2015-03-18 2016-09-21 Rottapharm Biotech S.r.l. New fyn kinase inhibitors
JP2018531916A (ja) * 2015-09-09 2018-11-01 ウォーレン シー. ラウ, 新規のfynキナーゼ阻害剤の方法、組成物、及び使用

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112023009656A2 (https=)
BR112023011738A2 (https=)
BR112023006729A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021015450A8 (https=)
BR102021015247A2 (https=)
BR102021015220A2 (https=)
BR102021014056A2 (https=)
BR102021014044A2 (https=)
BR102021013929A2 (https=)
BR102021012571A2 (https=)
BR102021012230A2 (https=)
BR102021012107A2 (https=)
BR102021012003A2 (https=)
BR102021010467A2 (https=)
BR102021009555A2 (https=)
BR102021009475A2 (https=)
BR102021007978A2 (https=)